Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

FastWave Medical Granted Second Utility Patent to Advance the Future of Cardiovascular Calcium Treatment


“Our second utility patent from the USPTO in just over a year highlights the rapid progress our team has made in advancing IVL treatments for cardiovascular calcium,” said Scott Nelson, CEO and Co-Founder of FastWave Medical.

FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the issuance of its second utility patent by the USPTO. This milestone showcases FastWave Medical’s unparalleled efficiency in developing novel intravascular lithotripsy (IVL) systems to address the $9 billion market.

“Our second utility patent from the USPTO in just over a year highlights the rapid progress our team has made in advancing IVL treatments for cardiovascular calcium,” said Scott Nelson, CEO and Co-Founder of FastWave Medical. “Our innovative technology platforms are designed to offer a more efficient, effective, and cost-conscious solution that addresses the current limitations with existing IVL interventions, propelling the industry forward at an unprecedented pace.”

Artery calcification is a critical predictor of adverse cardiac events. With an aging global population and a substantial number of individuals over 70 affected by the disease, the need for effective treatment options has never been more urgent. FastWave’s approach addresses this demand, providing cost-effective, minimally invasive solutions that substantially improve upon existing therapeutic options.

Accomplished interventional cardiologist, Dr. Sarang Mangalmurti, remarked, “Since its introduction, IVL technology has shown immense promise for treating complex calcium. I have high hopes that FastWave’s user-friendly systems will lead to improved clinical outcomes and a meaningful reduction in adverse events.”

About FastWave Medical Inc.

FastWave Medical, incubated by Big Sky Biomedical partners, focuses on developing IVL systems for calcific artery disease, prioritizing procedural efficiency and cost-effectiveness. FastWave’s goal is to transform the field by creating cutting-edge technologies that improve patient care and enhance the clinician experience. To learn more, visit https://fastwavemedical.com

About Big Sky Biomedical, LLC

Big Sky Biomedical, founded by medical device entrepreneurs with extensive cardiovascular expertise, specializes in swift, capital-efficient therapy development. With a mission to bring breakthrough medical technologies to market rapidly, Big Sky Biomedical accelerates innovation in the cardiovascular space. For more information, visit https://bigskybiomedical.com

Media Contact

mailto:media@fastwavemedical.com [media@fastwavemedical.com __title__ null]

Share article on social media or email:

U.S. Dermatology Partners Celebrates Milestone Opening of 100th Location as Part of their Outreach Program


U.S. Dermatology Partners reaches 100th location

U.S. Dermatology Partners Outreach Program

“Throughout our expansion efforts, we’ve maintained our values of doing what is good for people, our communities, and our organization. Sulphur Springs is no exception, and I’m looking forward to the value we can continue to drive across the U.S,” said Paul Singh, CEO at U.S. Dermatology Partners.

U.S. Dermatology Partners, one of the largest dermatology groups in the country, announced a significant milestone with the opening of its 100th location in Sulphur Springs, Texas. The new location is part of the organization’s Outreach Program, which is aimed at providing high-quality dermatological care to underserved and rural communities. During the next three years, thirty new offices will be opened in Texas, Oklahoma, Kansas, Missouri, Arizona, Colorado, Maryland, and Virginia as part of their commitment.

The 100th location in Sulphur Springs will offer convenient access to dermatology and skin cancer treatments to patients in Hopkins County, addressing the long-standing healthcare inequities that exist in rural areas. According to the Centers for Disease Control and Prevention (CDC), individuals living in rural areas face a greater likelihood of premature death from illnesses such as skin cancer, underscoring the significance of initiatives that bring healthcare services and specialists closer to home. Through the Outreach Program, U.S. Dermatology Partners is working to eliminate the long-standing challenges that patients in rural areas face, such as extensive wait times and having to travel long distances to receive care in urban and suburban areas.

“Reaching 100 offices is a significant moment and milestone for U.S. Dermatology Partners and I’m grateful for our team members who have helped us get to this point,” said Paul Singh, Chief Executive Officer at U.S. Dermatology Partners. “Throughout our expansion efforts, we’ve maintained our values of doing what is good for people, our communities, and our organization. Sulphur Springs is no exception, and I’m looking forward to the value that we can continue to drive across the U.S.”

U.S. Dermatology Partners was founded in 2012 and has grown to become a nationally recognized leader in dermatology for its patient-centered approach, innovative technology and treatment methods, leadership in clinical research, and coordinated care network. With the opening of its 100th location under the Outreach Program, U.S. Dermatology Partners builds on the program’s legacy of reaching patients closer to home in the communities they live and work.

“As an organization, we are proud to deliver care that is at or better than national benchmarks, and we are excited to be extending that commitment to rural communities across the country,” said Dr. Glenn Goldstein, chief medical officer at U.S. Dermatology Partners. “Improving accessibility to dermatological care for patients in these communities will allow for earlier detection of life-threatening conditions, such as skin cancer, ultimately leading to better health outcomes.”

The organization’s recent openings in Forney, Texas, Muskogee, Oklahoma, Cushing, Oklahoma, and now Sulphur Springs, Texas, further expands on their efforts for the Outreach Program and positions the organization to continue to deliver on their vision. U.S. Dermatology Partners looks forward to continuing to serve rural and underserved communities across the United States.

For more information, please visit http://www.usdermpartners.com.

###

About U.S. Dermatology Partners

U.S. Dermatology Partners is one of the largest dermatology practices in the country, caring for more than 1.5 million patients each year with 100 locations across eight states. U.S. Dermatology Partners patients have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network and benefit from the practice’s strong dermatology subspecialty thought leaders and medical advisory board. To be the best partner to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit http://www.usdermpartners.com.

Share article on social media or email:

Mount Sinai Launches Institute for Regenerative Medicine


“The Institute for Regenerative Medicine is dedicated to making transformations in how we treat regenerative diseases that impact millions of lives,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President for Academic Affairs of the Mount Sinai Health System.

Regenerative medicine—the process of replacing, engineering or regenerating human cells, tissues or organs—holds exciting potential for the field of health care. It could someday make it possible to grow a new kidney in a petri dish, repair damaged nerve cells, or reverse memory loss.

Continuing a commitment to advance medicine through forward-thinking approaches and groundbreaking discoveries, the Icahn School of Medicine at Mount Sinai is announcing the creation of the Institute for Regenerative Medicine to foster innovative research into new pathways to cure a host of diseases from leukemia to Alzheimer’s disease, breast cancer, and airway diseases—with the promise of improving medical care, quality of life, and longevity for all patients.

The Institute will advance and coordinate research and training in broad areas of regenerative biology and medicine across the basic science and clinical departments at Mount Sinai, and will encompass three centers that each focus on a subset of diseases and disorders. The Institute will include the Alper Center for Neural Development and Regeneration, the Center for Epithelial and Airway Biology and Regeneration, and the Center for Advancement of Blood Cancer Therapies.

“The Institute for Regenerative Medicine is dedicated to making transformations in how we treat regenerative diseases that impact millions of lives,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President for Academic Affairs of the Mount Sinai Health System. “Clinicians, scientists, and researchers from across Mount Sinai will continue to leverage expertise and discoveries in human biology and regenerative medicine, rapidly translating our findings to improve care and treatment for some of the most crippling developmental and degenerative conditions that impact our patients.”

Alper Center for Neural Development and Regeneration

Researchers, scientists, and clinicians at the Alper Center for Neural Development and Regeneration, which is co-sponsored by The Friedman Brain Institute, are expanding our knowledge and understanding of the brain, its development, and its role in disease. By using innovative research techniques including cell cultures, animal models, and human tissue studies, the scientists are seeking new insights into the workings of the nervous system, identifying new ways to prevent and treat brain disorders—and ultimately transforming the field of regenerative medicine for these devastating illnesses.

“The future of regenerative medicine for brain disorders lies in understanding how the brain develops and maintains itself throughout life,” said the Center’s Director, Nan Yang, PhD, Associate Professor of Neuroscience at Icahn Mount Sinai. “Our goal is to advance research on models of human disease and identify new preventive and therapeutic strategies that can lead to cures or relief for conditions such as neurodevelopmental disorders and neurodegeneration including autism, epilepsy, Parkinson’s, Alzheimer’s, and multiple sclerosis.”

Center for Epithelial and Airway Biology and Regeneration

The Center for Epithelial and Airway Biology and Regeneration, co-sponsored by the Institute for Airway Science, is fostering collaboration among scientists who treat diseases of epithelial tissues including the skin, lung, trachea, oral cavity, breast, liver, stomach, intestine, and esophagus. These conditions include sinus disorders, lung injury, tracheal and lung transplants, breast cancers, severe asthma, eczema, psoriasis, and hair loss. The scientists will advance research related to epithelial development, stem cells, regeneration, and disease. The Center will also offer pilot grant funding for innovative and collaborative research projects, and provide a formal ground for basic, translational, and clinical researchers to collaborate and promote their study findings for application in clinical settings.

“The Center for Epithelial and Airway Biology and Regeneration defines translational research. This unique cross-section of basic and clinical scientists provides a platform to tackle vexing clinical problems and offer real solutions,” said the Center’s Clinical Director, Eric Genden, MD, Isidore Friesner Professor and Chair of Otolaryngology – Head and Neck Surgery for the Mount Sinai Health System and Icahn Mount Sinai. “The Center promises to bring basic scientific discovery to the patient bedside and promote novel therapies for the benefit of our patients.” The Scientific Directors of the Center are Ya-Wen Chen, PhD, Assistant Professor of Otolaryngology and Cell, Developmental and Regenerative Biology, and Elena Ezhkova, PhD, Professor of Cell, Developmental and Regenerative Biology and Dermatology.

Center for Advancement of Blood Cancer Therapies

The Center for Advancement of Blood Cancer Therapies, co-sponsored by The Tisch Cancer Institute, is dedicated to the study of childhood and adult blood cancers and the development of new treatments, including conventional drugs and cell therapies. Of particular focus are human models of hematopoiesis and leukemia based on induced pluripotent stem cells and primary blood cells, combined with gene editing and single-cell technologies.

“This new Center brings together investigators with a commitment to blood research that directly aims to uncover mechanisms of human blood diseases such as adult and pediatric leukemias and myelodysplastic syndrome, and develop new therapeutics,” said Eirini Papapetrou, MD, PhD, Director of the Center for Advancement of Blood Cancer Therapies and Professor of Oncological Sciences at The Tisch Cancer Institute, a part of the Tisch Cancer Center at Mount Sinai. “Our researchers will capitalize on recent breakthroughs that have transformed the capabilities of experimentation with human cells, and the Center will foster close relationships between researchers and clinicians. We will continually identify new areas of synergy and encourage these interactions towards clinical translation of new findings emerging from labs affiliated with the Center.”

The Institute for Regenerative Medicine will also now house the Black Family Stem Cell Institute, founded at Mount Sinai in 2005 to integrate research in embryonic stem cells and adult stem cell biology. It will continue to promote research in stem cell biology to accelerate translation that improves care for patients in clinical settings, such as development of new drugs and cell-based therapies that are tested for safety and efficacy. Sarah E. Millar, PhD, who leads the Black Family Stem Cell Institute, will serve as the Director of the Institute for Regenerative Medicine.

“The broader platform of the Institute for Regenerative Medicine will enable us to expand research beyond stem cell-based therapies to other aspects of regenerative medicine including ex vivo development of human tissues for disease modeling, drug screening, and transplantation; approaches to prevent and treat neurodevelopmental and neurodegenerative diseases; new methods to promote regeneration of epithelial tissues such as skin, hair and lung; and blood cancer research,” said Dr. Millar, Senior Associate Dean for Basic Research and Lillian and Henry M. Stratton Professorial Chair of Cell, Developmental and Regenerative Biology at Icahn Mount Sinai. “Our aim is to accelerate innovation by integrating and synergizing these efforts across Mount Sinai’s campus and by providing an exciting, welcoming, diverse, and inclusive intellectual environment.”

Michael Rendl, MD, Professor of Cell, Developmental and Regenerative Biology and Associate Director of the Black Family Stem Cell Institute, will serve as Associate Director of the Institute of Regenerative Medicine.

About the Icahn School of Medicine at Mount Sinai

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.

Ranked No. 14 nationwide in National Institutes of Health funding and in the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 34 academic departments and 44 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, and gastrointestinal and liver diseases.

Icahn Mount Sinai offers highly competitive MD, PhD, and master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,600 clinical residents and fellows training throughout the Health System. In addition, more than 535 postdoctoral research fellows are in training within the Health System.

A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into health care products and services that benefit the public.

Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.

——————————————————-

  • Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.


####

Convergent Dental Secures $50M of Growth Capital


Convergent Dental

This latest infusion of capital will accelerate our vision of driving the broad-based adoption of Solea® and is expected to fully finance the company to profitable growth and beyond.

Convergent Dental, Inc. (the “Company”), the power behind the Solea® All-Tissue Dental Laser, today announced that the Company entered into a new credit facility of $40 million with Trinity Capital Inc. (NASDAQ: TRIN), a leading provider of diversified financial solutions to growth-stage companies. The Company has drawn $20 million at closing, and has the option to draw an additional $20 million, subject to the conditions under the agreement.

The Company also announced $10 million of equity financing led by existing investors Arboretum Ventures and Gund Investment, LLC, including $5 million of new equity and $5 million of existing investor notes converted to equity at the close. “This latest infusion of capital will accelerate our vision of driving the broad-based adoption of Solea® and is expected to fully finance the company to profitable growth and beyond,” said Robert L. Gershon, CEO of Convergent Dental.

Solea® is an all-tissue CO2 dental laser solution that uniquely enables dentists to perform virtually anesthesia-free, blood-free, and pain-free procedures. Convergent Dental unites this novel technology with success support, giving dentists the ability to elevate and expand their practices through improved efficiency, patient experience, and clinical effectiveness.

“We are proud to partner with the Convergent Dental team,” said Lauren Cosentino, Managing Director, Life Sciences of Trinity. “Solea brings exciting innovation to dentistry, allowing doctors to provide pain-free, patient centric care and we look forward to supporting their continued growth.”

Piper Sandler served as financial advisor to Convergent Dental on the transaction.

About Convergent Dental

Convergent Dental, Inc. is a privately owned dental equipment and technology company. The Company’s flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists can rely on. Solea® is a true breakthrough in dental laser technology that offers a completely different experience for both dentists and patients when compared to traditional instruments or any earlier laser treatment. Solea® enables increased new patient flow, better clinical outcomes, significant efficiency gains, and new procedures. Follow the company Instagram, Facebook, and LinkedIn.

About Trinity Capital Inc.

Trinity Capital Inc. (Nasdaq: TRIN, TRINL), an internally managed business development company, is a leading provider of diversified financial solutions to growth-stage companies with institutional equity investors. Trinity Capital’s investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans and equipment financings and equity-related investments. Trinity Capital believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience, and track record in lending to growth stage companies. For more information, please visit the Company’s website at http://www.trinitycap.com.

Share article on social media or email:

An Encouraging Autobiographical Story of Hope in the Face of Illness


News Image

I believe Holy Spirit laid it on my heart about 15 years ago that one day I would write a book about my experiences with chronic disease/illness, especially focusing on the invisibility of it all…

Author Erin Leopold motivates readers to never give up by sharing her own powerful story in Finding My Second Wind: Running Through Difficult Pain Finishing Strong with Warrior Faith ($17.49, paperback, 9781662872686; $8.99, e-book, 9781662872693).

When an invisible illness shook her world, Leopold, an athlete, had two options; wallow in self-pity or explore a deeper faith and hope in God. As her inspiring memoir thoughtfully shares, she used her heart of an athlete, courageously trusting in God. Leopold shares her personal journey of healing her spirit, soul, and body from a long struggle with chronic disease and how she partnered with God to achieve complete healing. Relatable with many readers, her road was not smooth so her faith and endurance faced bumps in the road while facing seemingly impossible obstacles. Leopold aims to help readers to never give up, by equipping them to become the most excellent version of who God destined them to be.

When asked what inspired the author to write this book, Leopold said, “I believe Holy Spirit laid it on my heart about 15 years ago that one day I would write a book about my experiences with chronic disease/illness, especially focusing on the invisibility of it all. Suffering is painful when what your life circumstances show do not match up to your physical condition. My heart aches for others dealing with Lyme disease.”

Erin Leopold holds a BA in Elementary Education. She is a fitness trainer, group exercise teacher, a wellness coach for 37 years, ACE certified in group exercise, APFA certified in holistic nutrition, a personal trainer in cardiac rehab/medical fitness for 8 years and holds other specialty certifications. She and her husband reside in South Carolina and love living in close proximity to beaches and mountains. Happiest in nature, she loves being active in God’s spectacular outdoor playground. She is passionate about living a life of purpose and sharing positive and encouraging messages of hope to her friends and community. She describes herself as having a competitive spirit. She is not good at being still. She loves spending time in the presence of the Lord, studying His Word and listening to great Bible teaching podcasts while she cycles or runs. You can follow Leopold on Facebook at Erin Dobb Leopold and erinleopold12 on Instagram.

###

Xulon Press, a division of Salem Media Group, is the world’s largest Christian self-publisher, with more than 15,000 titles published to date. Finding My Finding My Second Wind: Running Through Difficult Pain Finishing Strong with Warrior Faith is available online through

Share article on social media or email:

Upper Path Recovery Opens New Outpatient Addiction Treatment Center in Woodland Hills, California


Our team of addiction specialists is dedicated to providing compassionate care and customized treatment plans to help our clients achieve lasting recovery.

Located in the heart of Woodland Hills, Upper Path Recovery’s new facility offers a warm and welcoming environment for those struggling with addiction. The treatment center is staffed with experienced and professional addiction specialists who provide evidence-based treatments to help individuals achieve long-term recovery.

“We are thrilled to open our new facility in Woodland Hills and offer our proven addiction treatment programs to the community,” said Upper Path Recovery’s CEO. “Our team of addiction specialists is dedicated to providing compassionate care and customized treatment plans to help our clients achieve lasting recovery.”

Upper Path Recovery’s IOP program offers intensive treatment that allows individuals to receive comprehensive care while still being able to maintain their daily routines. PHP is a more structured program that provides individuals the necessary support to transition from a higher level of care to outpatient treatment. The standard outpatient program offers flexible scheduling and ongoing support for those who have completed a higher level of care. The sober living program provides a supportive and structured environment for those who are in early recovery and need a safe place to transition back into their everyday lives. Sober living is also available to those participating in outpatient treatment programs but lacks a home environment conducive to recovery.

The new facility is equipped with state-of-the-art amenities, including comfortable patient rooms, private therapy rooms, and a spacious community area for group therapy sessions. Upper Path Recovery’s team of addiction specialists includes licensed therapists, psychiatrists, and certified addiction counselors who work together to provide a multidisciplinary approach to addiction treatment.

Upper Path Recovery is now accepting new clients at its Woodland Hills location. For more information about the treatment programs offered, please visit https://upperpathrecovery.com/ or call (818)-748-4845.

About Upper Path Recovery:

Upper Path Recovery is a leading addiction treatment provider that offers comprehensive and personalized care to individuals struggling with addiction. By providing evidence-based treatment programs, including IOP, PHP, standard outpatient programs, and sober living, Upper Path Recovery’s mission is to help clients achieve long-term recovery.

Their team of addiction specialists includes licensed therapists, psychiatrists, and addiction counselors who work together to provide a multidisciplinary approach to addiction treatment.

For more information, please visit https://upperpathrecovery.com/ or call (818)-748-4845.

Share article on social media or email:

New Partnership with National Fatherhood Initiative® to Support Virginia Department of Behavioral Health and Developmental Services in Serving Fathers


Logo for National Fatherhood Initiative

“Collaborating with National Fatherhood Initiative® to bring the evidence-based 24:7 Dad® program to the fathers we serve will have a positive, lasting impact on hundreds of fathers and families across Virginia,” said Glenda Knight, Women’s Services Coordinator for the Virginia DBHDS.

National Fatherhood Initiative (NFI)®, the nation’s leading fatherhood organization, and the Virginia Department of Behavioral Health and Developmental Services (DBHDS) have embarked on a new partnership to implement 24:7 Dad®, the most widely used evidence-based fatherhood program in the U.S., in DBHDS-licensed community services boards across the state. This is DBHDS’ first father-focused departmental initiative.

Healthy father involvement is associated with better outcomes on nearly every measure of child well-being. Many factors influence a father’s ability to be involved in his child’s life, including trauma, mental illness, and addiction. DBHDS intends to more intentionally serve fathers who are accessing behavioral health services—alone or with a co-parent—by providing evidence-based programming designed to help fathers establish strong foundations for their families.

24:7 Dad® is NFI’s flagship evidence-based fatherhood program. The program is used by hundreds of U.S. organizations to train fathers to be involved, responsible, and committed 24 hours a day, 7 days a week. In January 2023, 47 DBHDS staff participated in a two-day webinar where they were trained in facilitating 24:7 Dad®. Trainees represented 10 DBHDS community services boards—each covering 5-8 Virginia counties—and their associated Project LINK programs. 24:7 Dad® will be integrated into this network of programs throughout 2023 and be delivered by clinicians, case managers, and peer recovery specialists.

DBHDS promotes dignity, choice, recovery, and the highest possible level of participation in work, relationships, and community life for individuals with mental illness, developmental disabilities, or substance-use disorders. The agency partners with 40 locally run community services boards to provide a comprehensive suite of evidence-based behavioral health and prevention services. Embedded within many of the community services boards are Project LINK programs, which coordinate services to address the specific needs of women and infants impacted by substance-use disorders. Several Project LINK programs provide direct services to men, such as case management and parenting education.

“Although co-ed parenting programs are beneficial to parents and caregivers, it is important to recognize the unique needs of fathers and allow fathers and caregivers to support each other on their parenting journey,” said Glenda Knight, Women’s Services Coordinator for the Virginia Department of Behavioral Health and Developmental Services. “That’s why we chose to collaborate with National Fatherhood Initiative® to bring the evidence-based 24:7 Dad® program to the fathers we serve. I firmly believe that our partnership will have a positive, lasting impact on fathers and families across Virginia.”

NFI comes alongside human services organizations and practitioners with a strengths-based approach to father engagement training, evidence-based and evidence-informed fatherhood programs, and other educational materials to help them be more father-inclusive. In addition to developing parent education skills, fathers who participate in the organization’s 24:7 Dad® program encourage other dads to take care of themselves so they can care for and be there for their children. Building resiliency, developing pro-fathering attitudes, and knowing where to get support can reduce the risk of child maltreatment.

“NFI is thrilled to assist the Virginia Department of Behavioral Health and Developmental Services in its efforts to engage fathers in our 24:7 Dad® program,” said Christopher Brown, President of National Fatherhood Initiative®. “Integrating the program in behavioral health treatment settings—both in the commu- nity and at home—presents a unique opportunity to champion fatherhood and provide direct support to fathers to help them be the type of dad they want to be for their children. This is just the beginning of what we hope will be a long-term partnership.”

For more information on NFI, visit http://www.fatherhood.org. More information on the DBHDS can be found at dbhds.virginia.gov/.

###

About National Fatherhood Initiative

National Fatherhood Initiative (NFI) was founded in 1994 to reverse our nation’s destructive trend toward father absence. Today, nearly 20 million American children live in homes where their biological fathers do not live. Yet, the fact remains that millions of families interact with human-service organizations every year that are primarily mother-focused. Therefore, NFI’s mission is to increase father involvement by equipping human service organizations and communities with the father engagement training, programs, and resources they need to be father-inclusive. Our vision is that all human service organizations and communities are proactively father-inclusive so that every child has an involved, responsible, and committed father in their lives.

Accordingly, we accomplish our mission by:

  • Educating all Americans, especially fathers, through social media, earned media, research, and free resources.
  • Equipping organizations and communities with fatherhood programs and resources and through training, planning, and technical assistance services.
  • Engaging and assisting organizations and communities to mobilize at the micro- and macro-level to increase fathers’ involvement in children’s lives.

For more information on NFI, visit http://www.fatherhood.org.

Share article on social media or email:

Seniors Helping Seniors® Franchise System Ends Q1 With Eight New Franchise Agreements Signed, 6 New Locations Opened


Seniors Helping Seniors® in-home care services, a franchisor with 125 franchise partners and 260 territories nationwide, has secured remarkable growth in recent years through the franchise model and its key offerings. The brand’s primary differentiator is its approach to staffing and caregiver-client matching, which allows mature adults to receive in-home non-medical care from individuals with similar life experiences. In the first quarter of 2023, the franchisor opened 6 new locations and executed eight new franchise agreements for a total of 14 new territories, laying the groundwork for expansion in Illinois, Texas, Colorado, California, Florida, New Jersey and Virginia.

“In 2022, we built relationships with 33 new franchise owners, which equated to 73 new territories granted,” explained Seniors Helping Seniors® in-home care President Namrata Yocom-Jan. “We had a significant increase in the number of clients that we serve across the country, and we’ve certainly been blessed with great caregivers. It’s been a win-win, not only from a franchise development perspective but also in terms of the care we’ve been able to provide our seniors and the jobs we’ve created for caregivers.”

While the demand for in-home care for mature populations continues to grow, with the U.S. Department of Health and Human Services reporting that nearly 70% of retirees will require some form of long-term care, Seniors Helping Seniors® is cornering the market with its unique care services and approach to caregiver-client matching.

“We are Bringing Love into the lives of Seniors with Dignity and Respect® and giving seniors the opportunity to continue to live at home and maintain their independence,” Yocom-Jan explained. “What we are providing is companionship by our caregivers who are closer in age and understand the aging process. They have empathy and understand what seniors are really going through rather than less mature care caregivers who just try to sympathize.”

“We want to create a friendship,” added Seniors Helping Seniors® in-home care Chief Operating Officer Daniel Jan. “It’s not just someone coming to do logistical services; it’s someone coming that truly enjoys spending time with the seniors. We really focus on the matching process to ensure a great fit.”

Looking to the remainder of the year, the Seniors Helping Seniors® system is looking to welcome an additional 25 franchise partners to its network, bringing its services to new cities nationwide. The concept is also working to develop a new website for franchise owners that will provide additional business support and streamline internal processes, empowering them to provide even better service to the seniors in their communities.

“About four years ago, we decided to implement changes to our programs. We began offering personal care, memory care, assistive technologies, telecare and more,” Yocom-Jan explained. “This gave us a strong foundation to reinvigorate the brand and refreshed franchise development offers. In the past 18 months, we have granted over 120 new territories, and we look forward to continuing along such a positive trajectory.”

ABOUT SENIORS HELPING SENIORS:

Seniors Helping Seniors® franchise system was founded by husband-and-wife duo Kiran and Philip Yocom. Kiran, who grew up in India, later worked to advance humanitarian efforts alongside Mother Teresa. After Kiran moved to the U.S. in 1995 and married her husband Philip, the Yocoms felt called to provide loving care to seniors and to cultivate an exchange of gifts at every generational level. Together, the Yocoms founded Seniors Helping Seniors® in-home services in 1998, opening the brand up to franchising in 2006. With a mission to be the most respected and rewarding homecare provider in the U.S., Seniors Helping Seniors® locations stand apart from competitors as the only company that prioritizes hiring active seniors to provide care services to their less-active counterparts. Seniors Helping Seniors® service aligns caregivers and clients based on the abilities and needs of both by offering a wide range of care services. Seniors Helping Seniors® network has grown to 200-plus locations, 125 franchise partners in 30-plus states and international markets. For more information on Seniors Helping Seniors® in-home care, visit seniorshelpingseniors.com.

Share article on social media or email:

Rich Nuts Goes All In for Testicular Cancer Awareness Month, Partners with TCAF to Help Spread Awareness and Support Early Detection


Richard Pauwels, founder of Rich Nuts

Richard Pauwels, founder of Rich Nuts, supports raising awareness about testicular cancer and support their important work. As he says, “Our nuts are important!”

Richard Pauwels, the founder of Rich Nuts, is thrilled to partner with the Testicular Cancer Awareness Foundation to help raise awareness about testicular cancer and support their important work. “Our nuts are important!”

Rich Nuts, the premium brand of sprouted nuts, has partnered with the Testicular Cancer Awareness Foundation (TCAF) to promote Testicular Cancer Awareness Month in April 2023. This partnership aims to bring light to a very serious issue in a light-hearted and fun way.

During the month of April 2023, Rich Nuts will donate 10% of every sale directly to TCAF to help support their mission of raising awareness about testicular cancer and promoting early detection. Additionally, all Rich Nuts shipments during April will include a prevention card with information on testing to help spread awareness of testicular cancer and its warning signs.

“At Rich Nuts, we are committed to promoting a healthy diet and lifestyle but also to spreading awareness about important health issues,” said Richard Pauwels, founder of Rich Nuts. “We are thrilled to partner with the Testicular Cancer Awareness Foundation to help raise awareness about testicular cancer and support their important work. Our nuts are important!

“Testicular cancer is the most common cancer in males between the ages of 15 and 44. It is a highly treatable cancer, but early detection is crucial. By partnering with TCAF, Rich Nuts hopes to help promote awareness about the importance of regular testing for testicular cancer.

“Until October 26, 2007, I was a mother, a wife, and a mortgage banker. On that day, however, my life was changed in immeasurable ways. That was the day my son’s battle with testicular cancer began at the early age of 13,” explained Kim Jones, founder of the Testicular Cancer Awareness Foundation. “I wondered why I, along with countless others, was unaware that testicular cancer was such a common diagnosis in young men. We are very excited to partner with Rich Nuts to promote Testicular Cancer Awareness Month. This partnership will help us reach a broader audience and spread awareness about testicular cancer prevention and early detection.

“For more information about Rich Nuts and the partnership with TCAF, visit https://richnuts.com/ or https://www.testicularcancerawarenessfoundation.org/.

Share article on social media or email:

SightMD Welcomes Yuchen Liu, OD to its Expert Team in New York


News Image

When asked what excites her most about joining the SightMD team, Dr. Liu said “I am excited to join SightMD because I’m really excited to serve the community in my second-hometown!”

SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Yuchen Liu, OD to its expert team.

Yuchen Liu, OD is an optometrist dedicated to providing her patients with the highest quality of care. Dr. Liu obtained her Doctor of Optometry degree at SUNY College of Optometry. She attended Stony Brook University for her undergraduate studies in Biology and AMS (Applied Mathematics and Statistics) and graduated cum laude. Dr. Liu is passionate about pediatric vision care. She had specialized training in pediatrics and vision therapy both in the United States and China and has accumulated extensive experience in Myopia control. Her endeavor is to establish the most appropriate treatment plan by communicating thoroughly with her patients and their parents. In her spare time, she enjoys playing the piano, reading books, and traveling. Dr. Liu grew up in China and relocated to the New York Metropolitan area in 2009. Now she is very excited to be back to her second hometown after 2 years of living and practicing in China. Dr. Yuchen Liu will be seeing patients at our locations at our eastern long island locations in Hampton Bays (223 W Montauk Hwy Ste 101, Hampton Bays, NY 11946), Riverhead (54 Commerce Dr Ste 6, Riverhead, NY 11901), Southampton (186 Old Town Rd, Southampton, NY 11968) and Southold (41705 County Rd 48, Southold, NY 11971).

When asked what excites her most about joining the SightMD team, Dr. Liu said “I am excited to join SightMD because I’m really excited to serve the community in my second-hometown! ”

SightMD is actively seeking ophthalmology professionals who are interested in joining our outstanding team. If you are an ophthalmology practice owner interested in merging or selling your practice, please contact our VP of Growth, Franc Galinanes, at (631) 396-8340 or fgalinanes@sightgrowthpartners.com

About SightMD

SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 80 eye care providers through the convenience of 40 locations across New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD as well as SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania.

For more information about SightMD, please visit https://www.sightmd.com/sightmd-ny/

Share article on social media or email: